A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...
Збережено в:
| Автори: | , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Англійська |
| Опубліковано: |
2009
|
| Онлайн доступ: | https://doi.org/10.1111/j.1600-0404.1997.tb00231.x |
| Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|